Pacira | PCRX - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Astellas Pharma JPY 43.52B 56.86B 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Cara Therapeutics USD -5.53M 621K 2025-09
Coherus Biosciences USD -37.64M 2.11M 2025-12
Heron Therapeutics USD -2.95M 14.54M 2025-12
Ironwood Pharmaceuticals USD 3.19M 457K 2024-12
J&J USD 5.24B 119M 2026-03
Ligand Pharmaceuticals USD -13.34M 58.13M 2026-03
Nektar Therapeutics USD -36.08M 978K 2025-12
Novo Nordisk DKK 26.89B 388M 2025-12
Omeros USD -32.23M 23.81M 2024-09
Pacira USD 2.92M 1.28M 2026-03
Perrigo USD -398.6M 1.02B 2026-03
Pfizer USD 2.69B 4.34B 2026-03
Supernus Pharmaceuticals USD -2.29M 1.81M 2026-03
Teva Pharmaceutical Industries USD 369M 111M 2026-03
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12
Xoma USD -17.24M 33.23M 2024-09
Zoetis USD 601M 2M 2026-03